Image by doug88888 via FlickrAs we near the 4th of July long weekend, some quick links to this week's pharma/supplement news:
"Neurontin Killed Our Husbands, We Believe" - Adverse reactions to Neurontin have been greatly underestimated and unreported, claims one person interviewed in the article. Link here.
FDA warns about delay in Offspring with Valproate: The US Food and Drug Administration (FDA) has issued a safety announcement to underline the increased risk for lower cognitive test scores among children born to mothers taking the antiseizure medication valproate sodium or the related products valproic acid and divalproex sodium during pregnancy, relative to other antiepileptic medications. Link.
Chelaton capsule maker signs Consent Decree: The Food and Drug Administration announced Thursday that Howard Sousa of the Artery Health Institute has signed a consent decree promising not to market his Advanced Formula EDTA Oral Chelation capsules as a drug. Link
FDA Warning Letters for June 2011: Medical device companies, those that make pharma products, food manufacturers that failed labelling. Link